Measures for COVID-19 prevention and treatment in immunocompromised persons reviewed.

This publication is a review concerning the prevention and treatment of SARS-CoV-2 infection, specifically focused on persons who are immunocompromised. The setting is the United States. The specific study type, phase, sample size, and follow-up duration are not reported. The intervention or exposure, comparator, and primary or secondary outcomes are also not detailed. No main results, including efficacy or effectiveness data, are provided. Safety and tolerability information, including adverse events, serious adverse events, and discontinuations, are not reported. Key limitations of the evidence are not specified. The funding sources and potential conflicts of interest are not reported. The practice relevance and any notes on causality or certainty are not provided. This summary describes a publication on a clinically important topic but does not convey specific evidence to guide practice.